Physician

Devendra C. Shah, M.D.

According to 2025 Medicare claims, Devendra Shah, M.D. (NPI: 1164418125) practices neuropsychiatry in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Mecklenburg, NC. Shah uses personal NPI as billing NPI and primary practice location at 28226-4548.

Shah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 86 traditional Medicare patients, billed 314 HCPCS/CPT codes, and received $19,772 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,548 prescription claims across 234 beneficiaries totaling $1,364,939 in drug costs, led by Ingrezza (Valbenazine Tosylate). Open Payments data shows 113 records totaling $2,478. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $31,416 to $19,772. In contrast, Part D prescription costs have risen steadily, from $709,765 to $1,364,939. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$21K$41K2015 Medicare payment: $31,416 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $35,158 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $41,112 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $35,924 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $40,862 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $32,111 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $32,291 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $27,255 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $24,377 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $19,772 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015151592$31,416
2016174624$35,158
2017199709$41,112
2018188624$35,924
2019194711$40,862
2020174612$32,111
2021147524$32,291
2022118455$27,255
2023114422$24,377
202486314$19,772

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$682K$1.4M2015 Drug cost: $709,765 (USD; Tot_Drug_Cst)2016 Drug cost: $624,913 (USD; Tot_Drug_Cst)2017 Drug cost: $636,205 (USD; Tot_Drug_Cst)2018 Drug cost: $800,114 (USD; Tot_Drug_Cst)2019 Drug cost: $849,888 (USD; Tot_Drug_Cst)2020 Drug cost: $865,246 (USD; Tot_Drug_Cst)2021 Drug cost: $948,573 (USD; Tot_Drug_Cst)2022 Drug cost: $965,542 (USD; Tot_Drug_Cst)2023 Drug cost: $1,160,623 (USD; Tot_Drug_Cst)2024 Drug cost: $1,364,939 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152745,290$709,765
20162785,232$624,913
20172795,541$636,205
20183045,778$800,114
20192955,578$849,888
20202715,420$865,246
20212375,287$948,573
20222264,850$965,542
20232164,683$1,160,623
20242344,548$1,364,939

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3860$89
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more77243$56

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
IngrezzaValbenazine Tosylate571,710$473,112
Invega SustennaPaliperidone Palmitate932,554$291,044
CaplytaLumateperone Tosylate732,175$124,991
VraylarCariprazine Hcl251,050$53,811
Abilify MaintenaAripiprazole20600$52,692

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.113$2,478Teva Pharmaceuticals USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Devendra C. Shah, M.D.?

Tedicare shows public-source Medicare data for Devendra C. Shah, M.D. (NPI 1164418125), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Devendra C. Shah, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Devendra C. Shah, M.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Devendra C. Shah, M.D. have Open Payments data?

Devendra C. Shah, M.D. has 113 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.